ResearchDx/Targeted Genomics receives FDA 510 (k) Clearance!
ResearchDx and Targeted Genomics are thrilled to announce that the GlutenID Celiac Genetic Health Risk Test has received FDA 510(k) clearance (K241456) with testing to be performed at ResearchDx’s PacificDx facility. Press Release Decision Summary
HistoIndex
FibroSIGHT™ is Here: A New Standard in Clinical Care of MASH Patients Read More
Prostatype Genomics
Prostatype Genomics receives CAP laboratory accreditation, achieves another milestone towards entering the US market for their groundbreaking Prostatype Gene Test Read More
Heranova
Heranova announces succesful CLIA certification and Early access launch of their groundbreaking HerResolve™, a Potential First FDA-Cleared, Non-Invasive Endometriosis Test Read More
Vesica Health
Vesica Health Announces Launch of AssureMDx Test to Improve Bladder Cancer Detection Read More